MedTrace Logo

Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

NCT02832362 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-06-29

No results posted yet for this study

Summary

This will be a single-center, randomized, parallel-group, placebo-controlled study to assess the local nasal tolerability and safety of multiple administrations of topically (intranasally) administered 1146A delivered by a nasal spray applicator in healthy adult participants

Conditions

  • Common Cold

Interventions

DRUG

Carbomer 980

Test product containing 0.5% carbomer 980 gel

OTHER

Placebo

Reference product containing vehicle without 0.5% carbomer 980 gel

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-11
Primary Completion
2016-07-10
Completion
2016-07-18

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832362 on ClinicalTrials.gov